You are here: Industry Insights > EU

News List

Dupixent approved in EU for atopic dermatitis in children pharmatimes
December 01, 2020
The European Commission has approved Sanofi and Regeneron’s biologic treatment Dupixent for the treatment of children aged six to 11 years with severe atopic dermatitis.
EU secures 80 million doses of Moderna COVID-19 vaccine europeanpharmaceuticalreview
November 30, 2020
The European Commission and Moderna have agreed that the company will supply at least 80 million doses of mRNA-1273, the company’s COVID-19 vaccine candidate.
EU to review Merck's targeted lung cancer drug pharmatimes
November 30, 2020
European regulators will review Merck's tepotinib for a specific type of lung cancer, having validated the drug's marketing application.
MSF welcomes EU pharmaceutical strategy but challenges key intellectual property issue expresspharma
November 27, 2020
According to a peer-reviewed analysis by MSF medicines used in the treatment of hepatitis c and cancer showed companies do not need SPCs to recoup R&D investments.
EU drugs watchdog expects first application for COVID-19 vaccine in days expresspharma
November 27, 2020
Europe’s drugs watchdog said on Thursday it expects to receive the first application for conditional marketing approval for a COVID-19 vaccine “in the coming days”, the latest step towards making a shot available outside the United States.
Sanofi’s meningococcal vaccine wins EU approval pharmatimes
November 25, 2020
French pharma company Sanofi has won approval from the European Commission (EC) for its meningococcal (MenACWY) vaccine MenQuadfi.
EU reaches deal to procure 160 million doses of Moderna’s Covid-19 vaccine candidate pharmaceutical-technology
November 25, 2020
The European Union has reached a deal to procure up to 160 million doses of US biotech Moderna’s experimental Covid-19 vaccine candidate.
EU reaches supply deal with Moderna for 160 mn doses of COVID-19 vaccine expresspharma
November 25, 2020
The European Commission (EU) has reached a deal with US biotech firm Moderna for the supply of its COVID-19 vaccine candidate, an EU official told Reuters.
EU signs COVID-19 vaccine deal with CureVac pharmatimes
November 19, 2020
The European Commission has signed a contract with CureVac for access to 405 million doses of its investigational COVID-19 vaccine.
EU secures 300 million doses of BioNTech, Pfizer’s COVID-19 vaccine pharmatimes
November 16, 2020
The European Commission has secured a supply deal with BioNTech and Pfizer for 300 million doses of their COVID-19 vaccine candidate.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page